The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To assess whether the anti-inflammatory effects of rosiglitazone result in improvements in
Rheumatoid Arthritis symptoms in patients for whom their existing Disease Modifying
Anti-Rheumatic Drug (DMARD) treatment does not give adequate relief.